ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,960Medicare Part D Prescriptions Filled, Including Refills

Rank: 694 out of 6645

$949K Total Retail Price of All Prescriptions

Rank: 357 out of 6645

556 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 6,863 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 626 320 1 6
AMLODIPINE BESYLATE 348 247 2 2
SUCRALFATE 330 219 3 256
LEVOTHYROXINE SODIUM 323 193 4 4
SIMVASTATIN 222 146 5 1
LEVETIRACETAM 222 51 5 119
MELOXICAM 214 125 7 46
LISINOPRIL 209 158 8 3
ALENDRONATE SODIUM 178 120 9 14
TRIAMTERENE-HCTZ 173 118 10 52
FAMOTIDINE 168 61 11 33
HYDROCODONE-ACETAMINOPHEN 155 109 S3 12 5
CARBAMAZEPINE 151 64 13 224
ZOLPIDEM TARTRATE 147 105 14 17
NEXIUM 146 91 15 40
METFORMIN HCL 137 121 16 7
ALBUTEROL SULFATE 131 108 17 112
GLYBURIDE 121 117 R 18 58
LAMOTRIGINE 113 0 19 284
TRAMADOL HCL 113 79 19 30
PANTOPRAZOLE SODIUM 110 78 21 29
BENAZEPRIL HCL 110 77 21 21
RISPERIDONE 108 24 23 93
OXCARBAZEPINE 83 36 24 416
BENZTROPINE MESYLATE 82 22 R 25 188
LOVASTATIN 82 64 25 15
ATENOLOL 80 68 27 8
MEGESTROL ACETATE 78 56 R 28 104
CARAFATE 76 17 29 469
JANUVIA 76 70 29 38
LOVAZA 76 52 29 68
BACLOFEN 75 39 32 100
GABAPENTIN 75 30 32 18
VIMPAT 75 0 32 404
TRIAMCINOLONE ACETONIDE 70 47 35 55
CYCLOBENZAPRINE HCL 70 42 R 35 157
DIOVAN 70 52 35 19
NIFEDIPINE ER 69 62 38 82
LOSARTAN POTASSIUM 68 54 39 12
AMOXICILLIN 68 48 39 107
FUROSEMIDE 67 50 41 11
SODIUM CHLORIDE 65 18 42 216
WARFARIN SODIUM 64 41 43 16
PAROXETINE HCL 63 19 44 72
METOPROLOL TARTRATE 62 36 45 13
HYDROCHLOROTHIAZIDE 61 31 46 9
VOLTAREN 59 49 47 108
TAMSULOSIN HCL 58 39 48 22
DEXILANT 56 30 49 102
PLAVIX 56 52 49 49
IPRATROPIUM BROMIDE 55 55 51 156
GLIMEPIRIDE 54 49 52 47
LEVOFLOXACIN 53 35 53 83
ENALAPRIL MALEATE 52 47 54 75
ATORVASTATIN CALCIUM 51 37 55 10
OXYBUTYNIN CHLORIDE 50 12 56 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.